Leukemia 2024 Apr 09
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
Related Questions
Specifically, in the setting of patients that have had a PR or VGPR and are not actively progressing.
New answer by Medical Oncologist at Mayo Clinic Rochester (December 14, 2024)
Achieving an early hem deep response (at least VGPR or better) is crucial for organ response and has demonstrated OS benefit. I would favor changing treatment even by cycle 4 ...